As Chief Operative Officer, David has launched and managed several successful clinical research sites over the course of his 18-year career. He has worked in every facet of the industry, including conducting phase one studies with many leading CROs and Sponsors.
His goal has always been to create a network of clinical sites unlike a SMO that is able to achieve high enrollment while ensuring the highest quality data.
“Our success is contributed to having a well-educated and diverse corporate team that is able to keep its finger on the pulse at all times, unlike a SMO we are a hands-on organization that knows how to achieve high enrollment while providing high quality data”
Jim brings over 25 years of financial leadership experience to ECN, partnering with investment sponsors and leadership teams in rapidly growing organizations.
With a broad understanding of operations, technology, sales, and human resources, Jim’s inclusive leadership approach promotes collaboration across the organization to develop results-focused strategies and outcomes. Jim is passionate about inspiring and collaborating towards sustainable, exceptional performance. He holds an MBA in both Finance and Information Technology, and is a CPA.
As Vice President of Operations, Melissa brings over 18+ years of experience to ECN. This spans clinical strategy and operations, clinical trial management, and project execution, ensuring seamless planning and implementation of clinical programs from Phase I to Phase III.
Her key strengths include building and empowering high-performing teams and enhancing program success, ensuring high-quality outcomes for clinical initiatives.
Board Certified Internist and Gastroenterologist bringing 40 years of medical experience to ECN.
Dr. Darani is a published KOL on vaccine trials that has completed over a 100 clinical trials throughout his esteemed career in Southern California.
Marina brings to ECN 10+ years of marketing experience in pharmaceutical and biotechnology industries, driving leads heading the patient recruitment marketing team.
Marina and her patient recruitment marketing team ensures around-the-clock engagement with potential participants, engaging through digital and social platforms to ensure leads and referrals.
Sarah and her team of quality inspectors understand the level of detail it takes to deliver a quality product, that’s why we inspect every chart at every visit before a subject leaves the clinic. “We take pride in the positive feedback we receive from our Sponsors, which in turn earns us repeat business. Quality is a never-ending process that we will never be truly satisfied with and we will always be striving to raise the bar against our competitors!”
As Operating Partner to ECN and Surge, Chip will work with the board and leadership team to manage the rapid growth the company is experiencing and secure increased enterprise value for the firm.
With his extensive experience and proven track record working with sponsors, partners, and investors to advance critical new therapies, Chip will play a pivotal role in helping ECN continue to grow and meet the increasingly demanding and complex requirements of today’s research studies. Chip’s sector experience includes more than a decade at Quintiles (now IQVIA) where as a member of NovaQuest, the strategic investing and partnering arm of Quintiles, he led a global team that worked with emerging and mid-size biotechs to advance new therapies. Following Quintiles, Chip served as CEO of Cognitive Research Corporation, a rapidly growing, therapeutically focused CRO targeting the CNS markets.
Jon Ruckle MD brings over 25 years of clinical trial experience to ECN.
He has served as an Investigator for over 350 clinical trials.